Handelsavisen
prelaunch
Companies ›Consumer Non Cyclicals ›CAMP.JK
CA
CAMP.JK — IDX (Jakarta) Food Processing

Camp.Jk

$198,00
Open in Charts → Attach watcher ⌖
— —
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
0,00 %
Op margin
7,1 %
ROE
7,4 %
Net margin
6,4 %
Debt / equity
0,00
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
—
Open
—
Next earnings
2026-10-28
Ex-dividend
—
TR 1Y
—
About

CAMP operates in the food processing industry, manufacturing and distributing a range of food products, primarily in the Indonesian market.

Business. CAMP operates in the food processing industry, manufacturing and distributing a range of food products, primarily in the Indonesian market.

Classification92 %
SectorConsumer Non-Cyclicals
Business sectorFood & Beverages
IndustryFood Processing
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
JANUS HENDERSON GROUP PLC
largest disclosed fund holder
Profitability→
7,4 %
return on equity
Quality
—
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning CAMP.

    • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples · THIS SECTOR−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to CAMP.JK. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    CAMP operates in the food processing industry, manufacturing and distributing a range of food products, primarily in the Indonesian market.

    Classification92 %
    SectorConsumer Non-Cyclicals
    Business sectorFood & Beverages
    IndustryFood Processing
    AI synthesis
    GENERATED

    CAMP maintains a strong liquidity position, with a current ratio of 5.03, indicating a robust ability to meet short-term obligations. The company has no long-term debt, and its total liabilities amount to 167.88 billion IDR, significantly lower than its total equity of 1.01 trillion IDR. This capital structure supports a debt-to-equity ratio of 0.0, suggesting a conservative approach to leverage.

    Profitability metrics show CAMP is performing well relative to industry norms. The company's return on equity (ROE) is 7.43%, and its return on assets (ROA) is 6.37%. These figures suggest efficient use of equity and assets to generate profit, aligning with the industry's preference for high ROIC and ROE as key performance indicators.

    Geographically, CAMP's revenue is concentrated in Indonesia, with no disclosed international operations. The company's business is primarily driven by domestic demand, and it operates through a single business segment focused on food processing. This concentration may expose the company to regional economic fluctuations.

    CAMP's growth trajectory is supported by strong operating cash flow of 100.32 billion IDR and free cash flow of 61.12 billion IDR. The company's capital expenditure of -98.02 billion IDR indicates a significant investment in infrastructure or expansion. Looking ahead, the company is expected to maintain its growth momentum, supported by its strong liquidity and operational efficiency.

    Risk factors for CAMP are currently low, with no immediate filing-based liquidity or dilution flags detected. The company's conservative capital structure and strong liquidity position reduce the risk of financial distress. Additionally, the absence of long-term debt and the low dilution potential suggest a stable equity base.

    Recent events, including filings and transcripts, have not indicated any significant changes in the company's strategic direction or operational performance. The company continues to focus on its core food processing business, with no disclosed plans for major restructuring or new market entry.

    Key takeaways
    • CAMP has a strong liquidity position with a current ratio of 5.03 and no long-term debt.
    • The company's ROE of 7.43% and ROA of 6.37% indicate efficient use of equity and assets.
    • CAMP's business is concentrated in Indonesia, with no international operations disclosed.
    • The company's growth is supported by strong operating and free cash flows.
    • Risk factors are currently low, with no immediate liquidity or dilution concerns.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $198,00
    Market cap
    —
    Enterprise valueⓘ
    —
    P/Eⓘ
    —
    Non-GAAP P/Eⓘ
    —
    EV / Revenueⓘ
    —
    EV / Op incomeⓘ
    —
    EV / OCFⓘ
    —
    P / Bⓘ
    —
    P / Tangible bookⓘ
    —
    Tangible book
    $1.01T
    Net cashⓘ
    —
    Current ratioⓘ
    5.0
    Debt / equityⓘ
    0.0
    ROAⓘ
    6.4%
    ROEⓘ
    7.4%
    Cash conversionⓘ
    134.0%
    CapEx / revenueⓘ
    -8.3%
    SBC / revenueⓘ
    —
    Dilution ratioⓘ
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin7,1 %Above median
    Net Margin6,4 %Above median
    ROE7,4 %Above median
    Capex / Rev-8,3 %Below median
    D/E0,00Above P75
    Cash Conv1,34Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 2 354 500 sh15 grants11 insiders
    • Stewart MurrayDirector · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • Nashat AmirDirector, 10% owner · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • Holtzman Steven HDirector · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • Schwab Andrew J.Director, 10% owner · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • WILLIAMS DOUGLAS EDirector · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • Young Richard ADirector · Stock Option (Right to Buy) → Common StockAcquired 28 000 @ $4,34grant · 2026-06-10
    • Maricich YuriChief Medical Officer · Stock Option (Right to Buy) → Common StockAcquired 215 000 @ $4,46grant · 2026-04-01
    • MacLean Michael FDirector · Stock Option (Right to Buy) → Common StockAcquired 56 000 @ $4,46grant · 2026-04-01
    • Mandel-Brehm JoshDirector, Chief Executive Officer · Stock Option (Right to Buy) → Common StockAcquired 580 000 @ $4,46grant · 2026-04-01
    • Tardiff DanielChief Scientific Officer · Stock Option (Right to Buy) → Common StockAcquired 170 000 @ $4,46grant · 2026-04-01
    • Gold KellyChief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 215 000 @ $4,46grant · 2026-04-01
    • Mandel-Brehm JoshDirector, Chief Executive Officer · Stock Option (Right to Buy) → Common StockAcquired 425 000 @ $6,01grant · 2025-12-11
    • Tardiff DanielChief Scientific Officer · Stock Option (Right to Buy) → Common StockAcquired 145 500 @ $6,01grant · 2025-12-11
    • Maricich YuriChief Medical Officer · Stock Option (Right to Buy) → Common StockAcquired 190 000 @ $6,01grant · 2025-12-11
    • Gold KellyChief Financial Officer · Stock Option (Right to Buy) → Common StockAcquired 190 000 @ $6,01grant · 2025-12-11

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • CAMP.JK Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,01 %$28M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$22M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$10M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$2M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$1M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$0M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net buying9 buys · 0 sellsnet $8,6M8 insiders · last 365d
    • Nashat AmirDirector, 10% owner · Common StockBought 85 468 @ $1,53$131K · 2025-09-11
    • Schwab Andrew J.Director, 10% owner · Common StockOther 2 941 176 @ $1,53$4,5M · 2025-09-11
    • 5AM Partners VI, LLC10% owner · Common StockBought 2 941 176 @ $1,53$4,5M · 2025-09-11
    • Polaris Management Co. VII, L.L.C.10% owner · Common StockBought 1 221 721 @ $1,53$1,9M · 2025-09-11
    • Polaris Management Co. VII, L.L.C.10% owner · Common StockBought 85 468 @ $1,53$131K · 2025-09-11
    • Nashat AmirDirector, 10% owner · Common StockBought 1 221 721 @ $1,53$1,9M · 2025-09-11
    • Maricich YuriChief Medical Officer · Common StockBought 6 060 @ $1,65$10K · 2025-09-11
    • Gold KellyChief Financial Officer · Common StockBought 6 060 @ $1,65$10K · 2025-09-11
    • Mandel-Brehm JoshDirector, Chief Executive Officer · Common StockBought 6 060 @ $1,65$10K · 2025-09-11
    • Young Richard ADirector · Common StockBought 15 151 @ $1,65$25K · 2025-09-11

    Short positioning

    1.4Mshares short+10.0% vs prior
    9.1days to cover
    54.0%short of daily vol
    113.6Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    CAMP.JKCanonical
    IDX (Jakarta) · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Current ratio (FY 2025-12-31): 7.35xDerived (calculated)
    • Debt-to-equity (FY 2025-12-31): 1.47xDerived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -36.7%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -55.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 76.0%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 71.0%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 1.0%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 50.4%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -24.5%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 362.3%Derived (calculated)
    • Net margin (FY 2025-12-31): -2,298.5%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 436.5%Derived (calculated)
    • Return on equity (FY 2025-12-31): -168.5%Derived (calculated)
    • R&D expense (YoY) (2025-12-31 vs 2024-12-31): -1.6%Derived (calculated)
    • Return on assets (FY 2025-12-31): -68.2%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 35.1%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 76.0%Derived (calculated)
    • Capex (annual): USD 279KSEC XBRL filing
    • Operating income (annual): USD -52.55MSEC XBRL filing
    • Revenue (annual): USD 3.5MSEC XBRL filing
    • Shareholders' equity (annual): USD 47.7MSEC XBRL filing
    • Cash & equivalents (annual): USD 109.52MSEC XBRL filing
    • Net income (annual): USD -80.4MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -3SEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-12FILING8-K filing →
    2026-06-10 00:00 UTCINSIDER6 insider transactions — 2026-06 6 derivative
    2026-06-10INSIDERYoung Richard A acquired 28.0k sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERWILLIAMS DOUGLAS E acquired 28.0k sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERSchwab Andrew J. acquired 28.0k sh Stock Option (Right to Buy) — Director, 10% owner
    2026-06-10INSIDERHoltzman Steven H acquired 28.0k sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERStewart Murray acquired 28.0k sh Stock Option (Right to Buy) — Director
    2026-06-10INSIDERNashat Amir acquired 28.0k sh Stock Option (Right to Buy) — Director, 10% owner
    2026-05-14FILING8-K filing →
    2026-05-07FILING10-Q filing →
    2026-05-07FILING8-K filing →
    2026-04-23FILINGDEF 14A filing →
    2026-04-01 00:00 UTCINSIDER5 insider transactions — 2026-04 5 derivative
    2026-04-01INSIDERMandel-Brehm Josh acquired 580.0k sh Stock Option (Right to Buy) — Director, Chief Executive Officer
    2026-04-01INSIDERTardiff Daniel acquired 170.0k sh Stock Option (Right to Buy) — Chief Scientific Officer
    2026-04-01INSIDERMaricich Yuri acquired 215.0k sh Stock Option (Right to Buy) — Chief Medical Officer
    2026-04-01INSIDERGold Kelly acquired 215.0k sh Stock Option (Right to Buy) — Chief Financial Officer
    2026-04-01INSIDERMacLean Michael F acquired 56.0k sh Stock Option (Right to Buy) — Director
    2026-03-24FILING8-K filing →
    2026-03-05FILING10-K filing →
    2026-03-05FILING8-K filing →
    2026-01-09FILING8-K filing →
    2025-12-23FILING8-K filing →
    2025-12-18FILING8-K filing →
    2025-12-18FILING424B5 filing →
    2025-12-11 00:00 UTCINSIDER4 insider transactions — 2025-12 4 derivative
    2025-12-11INSIDERGold Kelly acquired 190.0k sh Stock Option (Right to Buy) — Chief Financial Officer
    2025-12-11INSIDERTardiff Daniel acquired 145.5k sh Stock Option (Right to Buy) — Chief Scientific Officer
    2025-12-11INSIDERMaricich Yuri acquired 190.0k sh Stock Option (Right to Buy) — Chief Medical Officer
    2025-12-11INSIDERMandel-Brehm Josh acquired 425.0k sh Stock Option (Right to Buy) — Director, Chief Executive Officer
    2025-09-11 00:00 UTCINSIDER10 insider transactions — 2025-09 · net buy $13.1M
    2025-09-11INSIDERNashat Amir bought 85.5k sh — Director, 10% owner ~$131k
    2025-09-11INSIDERSchwab Andrew J. transacted 2.94M sh — Director, 10% owner ~$4.50M
    2025-09-11INSIDER5AM Partners VI, LLC bought 2.94M sh — 10% owner ~$4.50M
    2025-09-11INSIDERPolaris Management Co. VII, L.L.C. bought 1.22M sh — 10% owner ~$1.87M
    2025-09-11INSIDERPolaris Management Co. VII, L.L.C. bought 85.5k sh — 10% owner ~$131k
    2025-09-11INSIDERNashat Amir bought 1.22M sh — Director, 10% owner ~$1.87M
    2025-09-11INSIDERMaricich Yuri bought 6.1k sh — Chief Medical Officer ~$10k
    2025-09-11INSIDERGold Kelly bought 6.1k sh — Chief Financial Officer ~$10k
    Showing the 40 most recent of 42 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage